Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 20
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    An initial exploration of in-situ underwater genetic sequencing

    Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

    Sequencing the genomes of all known kākāpō

    The goal of this project is to sequence the genome's of all 125 known living kākāpō. Please help us to save...

    Restoring native oysters to Biscayne Bay, as a tool to mitigate algal blooms

    The hypothesis is native oysters can be reestablished due to new freshwater flows to Biscayne Bay.Oysters...

    Backer Badge Funded